PT881901E - Novas associacoes de principios activos contendo clopidogrel e um agente anti-trombotico - Google Patents

Novas associacoes de principios activos contendo clopidogrel e um agente anti-trombotico

Info

Publication number
PT881901E
PT881901E PT97905218T PT97905218T PT881901E PT 881901 E PT881901 E PT 881901E PT 97905218 T PT97905218 T PT 97905218T PT 97905218 T PT97905218 T PT 97905218T PT 881901 E PT881901 E PT 881901E
Authority
PT
Portugal
Prior art keywords
active principles
antitrombotic
agent
pct
containing clopidogrel
Prior art date
Application number
PT97905218T
Other languages
English (en)
Inventor
Andre Bernat
Jean-Marc Herbert
Pierre Savi
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT881901(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of PT881901E publication Critical patent/PT881901E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
PT97905218T 1996-02-19 1997-02-17 Novas associacoes de principios activos contendo clopidogrel e um agente anti-trombotico PT881901E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9602027A FR2744918B1 (fr) 1996-02-19 1996-02-19 Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique

Publications (1)

Publication Number Publication Date
PT881901E true PT881901E (pt) 2002-09-30

Family

ID=9489354

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97905218T PT881901E (pt) 1996-02-19 1997-02-17 Novas associacoes de principios activos contendo clopidogrel e um agente anti-trombotico

Country Status (29)

Country Link
US (1) US5989578A (pt)
EP (1) EP0881901B1 (pt)
JP (1) JP3662028B2 (pt)
KR (1) KR100295345B1 (pt)
CN (1) CN1116042C (pt)
AT (1) ATE218870T1 (pt)
AU (1) AU715655B2 (pt)
BR (1) BR9707556A (pt)
CA (1) CA2246289C (pt)
CZ (1) CZ292363B6 (pt)
DE (2) DE122010000030I2 (pt)
DK (1) DK0881901T3 (pt)
EE (1) EE03513B1 (pt)
ES (1) ES2176684T3 (pt)
FR (1) FR2744918B1 (pt)
HK (1) HK1017850A1 (pt)
HU (1) HU225036B1 (pt)
IL (1) IL125848A (pt)
IS (1) IS1892B (pt)
NO (2) NO317747B3 (pt)
NZ (1) NZ331444A (pt)
PL (1) PL187292B1 (pt)
PT (1) PT881901E (pt)
RU (1) RU2184547C2 (pt)
SI (1) SI0881901T1 (pt)
SK (1) SK284285B6 (pt)
TR (1) TR199801608T2 (pt)
UA (1) UA51695C2 (pt)
WO (1) WO1997029753A1 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002506024A (ja) * 1998-03-13 2002-02-26 メルク エンド カムパニー インコーポレーテッド 急性冠動脈虚血症候群および関連状態に対する併用療法および組成物
EP1087775B1 (en) 1998-06-17 2005-08-17 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
PT1350511E (pt) 2000-12-25 2008-10-28 Ube Industries Composições medicinais contendo aspirina
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
FR2832929A1 (fr) * 2001-12-05 2003-06-06 Sanofi Synthelabo Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
AU2003270861A1 (en) * 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
WO2005007868A2 (en) * 2003-07-08 2005-01-27 Accumetrics, Inc. Controlled platelet activation to monitor therapy of adp antagonists
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
HUP0400982A2 (en) * 2004-05-17 2006-08-28 Chemor Kutato New veterinary product for honeybees
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
EP1926736A4 (en) * 2005-09-21 2010-08-25 Chong Kun Dang Pharm Corp NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF
WO2008048083A1 (es) * 2006-10-17 2008-04-24 Espinosa Abdala Leopoldo De Je Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de) 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
MX2009011619A (es) * 2007-04-27 2010-01-18 Cydex Pharmaceuticals Inc Formulaciones que contienen clopidogrel y eter sulfoalquilico-ciclodextrina y metodos de uso.
EP2255797A4 (en) * 2008-02-22 2011-09-07 Hanall Biopharma Co Ltd COMPOSITE PREPARATION
DE102008032361A1 (de) 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
WO2010132711A1 (en) 2009-05-13 2010-11-18 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
CN102803199B (zh) 2009-06-25 2015-04-15 泰特拉有限公司 乙酰水杨酸盐
US8563574B2 (en) 2009-12-07 2013-10-22 Academic Pharmaceuticals, Inc. Parenteral formulation of clopidogrel
CN102389436A (zh) * 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种抗血小板聚集的药物组合物
KR101675501B1 (ko) * 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en) 2011-11-26 2013-08-20 Academic Pharmaceuticals, Inc. Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
KR101473268B1 (ko) * 2012-03-09 2014-12-16 주식회사유한양행 클로피도그렐과 아스피린을 포함하는 약학 조성물 및 그의 제조방법
CN103720700A (zh) * 2012-10-10 2014-04-16 江苏威凯尔医药科技有限公司 含有阿斯匹林和维卡格雷的药用组合物
EP2796145B1 (en) 2013-04-22 2017-11-01 CSL Ltd. A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge
KR101502588B1 (ko) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
JP5905165B2 (ja) * 2013-08-02 2016-04-20 サノフイ アセチルサリチル酸およびクロピドグレルを含む医薬錠剤
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) * 2020-08-14 2021-03-31 Алексей Викторович Марочков Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
US20230059869A1 (en) 2021-08-03 2023-02-23 Liqmeds Worldwide Limited Oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
NZ331444A (en) 2001-04-27
HUP9901144A3 (en) 2001-04-28
PL187292B1 (pl) 2004-06-30
EP0881901A1 (fr) 1998-12-09
JPH11510818A (ja) 1999-09-21
KR100295345B1 (ko) 2001-08-07
US5989578A (en) 1999-11-23
TR199801608T2 (xx) 1998-11-23
AU715655B2 (en) 2000-02-10
IL125848A0 (en) 1999-04-11
DE69713287T2 (de) 2002-12-19
IS1892B (is) 2003-10-20
FR2744918B1 (fr) 1998-05-07
NO983812L (no) 1998-10-09
CN1116042C (zh) 2003-07-30
ES2176684T3 (es) 2002-12-01
SI0881901T1 (en) 2002-10-31
SK110598A3 (en) 1999-01-11
NO2010015I2 (no) 2012-11-12
IL125848A (en) 2000-11-21
DK0881901T3 (da) 2002-10-07
NO317747B3 (no) 2011-10-03
EE9800247A (et) 1999-02-15
RU2184547C2 (ru) 2002-07-10
DE122010000030I1 (de) 2010-10-21
CN1211922A (zh) 1999-03-24
IS4827A (is) 1998-08-18
HUP9901144A2 (hu) 1999-09-28
WO1997029753A1 (fr) 1997-08-21
NO2010015I1 (no) 2010-07-26
CZ292363B6 (cs) 2003-09-17
CA2246289A1 (fr) 1997-08-21
NO983812D0 (no) 1998-08-19
ATE218870T1 (de) 2002-06-15
AU1884497A (en) 1997-09-02
DE69713287D1 (de) 2002-07-18
KR19990087163A (ko) 1999-12-15
JP3662028B2 (ja) 2005-06-22
SK284285B6 (sk) 2005-01-03
UA51695C2 (uk) 2002-12-16
HU225036B1 (en) 2006-05-29
HK1017850A1 (en) 1999-12-03
EP0881901B1 (fr) 2002-06-12
DE122010000030I2 (de) 2012-06-21
FR2744918A1 (fr) 1997-08-22
CZ249998A3 (cs) 1998-11-11
CA2246289C (fr) 2003-12-16
PL327923A1 (en) 1999-01-04
BR9707556A (pt) 1999-07-27
EE03513B1 (et) 2001-10-15
NO317747B1 (no) 2004-12-13

Similar Documents

Publication Publication Date Title
PT881901E (pt) Novas associacoes de principios activos contendo clopidogrel e um agente anti-trombotico
HRP20020880B1 (en) New pharmaceutical composition
DK0858328T3 (da) Stabile præparater indeholdende N-propargyl-1-aminoindan
ATE239709T1 (de) Racemisches huperzin a
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
ZA966047B (en) Therapeutic agents.
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
PT1007040E (pt) Utilizacao de fanquinona no tratamento da doenca de alzheimer
GEP20063719B (en) Prevention of Migraine Recurrence
FI963394A (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
EE04347B1 (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, neid sisaldav ravim ja farmatseutiline kompositsioon
GB9802542D0 (en) New use
GB9513750D0 (en) Use of allylamines
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
KR960033451A (ko) 나트륨 치환 트립토판을 포함하는 b형 간염 치료제